Valuation: TELES

Market Cap 1.27M 1.47M 1.19M 1.09M 2.06M 140M 2.08M 13.93M 5.47M 69.85M 5.51M 5.39M 231M P/E 2024
-4.29x
P/E 2025 -4.4x
Enterprise Value 4.97M 5.73M 4.63M 4.26M 8.04M 545M 8.13M 54.4M 21.35M 273M 21.54M 21.06M 904M EV / Sales 2024
19.8x
EV / Sales 2025 90.1x
Free-Float
26.91%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 2023-12-31
Director TitleAgeSince
Chairman - -
Director/Board Member - 2019-08-11
Director/Board Member - 2019-08-11
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 1.46M
+0.24%-0.66%-3.27%+27.62% 231B
-0.87%-1.59%+8.91%+42.85% 195B
-1.54%-0.62%-13.01%+45.45% 154B
-0.54%-3.26%-23.03%+16.92% 80.51B
+0.40%-3.45%-1.37%-4.73% 77.76B
-0.60%-4.53%+26.58%+26.28% 74.64B
+0.09%+2.54%+4.46%+5.01% 57.85B
-1.14%-3.97%+8.75%+78.28% 56.39B
-3.26%-7.42%+15.76%+57.55% 50.31B
Average -0.74%-1.70%+2.64%+32.80% 108.62B
Weighted average by Cap. -0.70%-1.49%+0.55%+33.03%

Financials

2024 2025
Net sales 207K 239K 193K 178K 335K 22.74M 339K 2.27M 890K 11.38M 898K 878K 37.68M 68.54K 79.14K 63.89K 58.76K 111K 7.52M 112K 751K 295K 3.76M 297K 291K 12.47M
Net income -836K -965K -779K -716K -1.35M -91.73M -1.37M -9.15M -3.59M -45.9M -3.62M -3.54M -152M -564K -651K -526K -483K -913K -61.9M -923K -6.18M -2.42M -30.97M -2.45M -2.39M -103M
Net Debt 510K 589K 476K 438K 826K 56.03M 835K 5.59M 2.19M 28.04M 2.21M 2.16M 92.85M 3.69M 4.27M 3.44M 3.17M 5.98M 406M 6.05M 40.47M 15.88M 203M 16.02M 15.67M 672M
Logo TELES
Arzneiwerk VIDA AG, formerly Teles AG, is a Germany-based financial holding company. The Company is active in the pharmaceutical segment, where it focuses on the growth area of Specialty Pharma in Germany and Europe. Specialty Pharma usually includes high-priced drugs for chronic, complex, or rare diseases. It focuses on six indication areas: oncology, neurology, autoimmune diseases, ophthalmology, hemophilia, and infectious diseases. The Pharma segment combines pharmaceutical supply with a focus on digitalization and process optimization along the pharmaceutical value chains and the management of large data volumes in the pharmaceutical industry.
Employees
-